FDA Clearance Tracker · P080025-S248
InterStim® Therapy System, Verify® Evaluation System
Last checked: Nov 20, 2026Latest source record: Mar 14, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Mar 14, 2023
Approved
Time to decision
428 days
Received Jan 10, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P080025-S248
- Device name
- InterStim® Therapy System, Verify® Evaluation System
- Applicant
- Medtronic Neuromodulation
- Applicant location
- Minneapolis, MN
- Received
- Jan 10, 2022
- Decided
- Mar 14, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P080025
Device type
- Device class
- Class III
- Regulation
- 21 CFR 876.5270
FDA's approval statement
As written in FDA's record.
Approval with conditions for Medtronics updated use of third party applications on the CT900 and HH90 devices.
Source documents
Other decisions for Medtronic Neuromodulation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P240011 · Decided Sep 18, 2025 · 532 days after receipt
Device type: Stimulator, tibial, electrical, implantable, for urinary incontinence (QPT) · GI, Urology & Nephrology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.